About Scleroderma >
COVID-19 >
+ info

COVID-19

Vaccine news

With the approval of two vaccines in Canada for Covid-19, there are many questions about the safety and efficacy of the vaccines for people living with scleroderma.

The Scleroderma Foundation in the United States has provided information and recommendations on COVID-19 vaccines which can be accessed using the link below. This page has highly credible information from some of the top experts in the world. Scleroderma Manitoba recommends that you discuss medical decisions regarding the vaccine with your doctor.

Scleroderma Foundation: Questions and Answers Regarding the COVID-19 Vaccine

COVID-19 presents important challenges for people affected by Scleroderma. This page provides available resources and pertinent information for Scleroderma patients, as well as initiatives to support the organization and patients during these difficult times.

If you have questions about mental health, well-being, or coping with COVID-19, SPIN Director, Dr. Brett Thombs, and the SPIN Team are ready to provide answers. Please submit your questions here.

SPIN Series: Living with Covid

SPIN (The Scleroderma Patient Information Network) is offering weekly educational webinars, starting February 2nd and held every Wednesday thereafter, for a total of 11 webinars.

Facebook Event page registration for the first session here.

Webinar February, March, and April Line Up:

02/02: Healthy information management – Laura Dyas
10/02: Worry management – Ghassan El-Baalbaki
17/02: Relaxation techniques – Ghassan El-Baalbaki
24/02: Adapted home exercise – Kelsey Ellis & Delaney Duchek
03/03: Home activity engagement – Laura Bustamante
10/03: Worry management (Part 2) – Ghassan El-Baalbaki
17/03: Relaxation techniques (Part 2) – Ghassan El-Baalbaki
24/03: Adapted home exercise (Part 2) – Kelsey Ellis & Delaney Duchek
31/03: Home activity engagement (Part 2) – Laura Bustamante
07/04: Worry management (Part 3) – Ghassan El-Baalbaki
14/04: Adapted home exercise (Part 3) – Kelsey Ellis & Delaney Duchek

More answers to your questions

Immunosuppression is a risk factor, and having an interstitial lung disease (ILD) or Scleroderma without an ILD puts you at a slightly higher risk.

If you have questions, watch this video forum captured on March 21 2020.

Scleroderma & COVID-19 : A conversation with the experts 

Participants were invited to submit their questions concerning COVID-19 and Scleroderma in advance via an online Qualtrics questionnaire or to ask their questions directly to a team of five experienced panelists, Mrs. Maureen Sauvé, Dr. Janet Pope, Dr. John Varga, Dr. Don Sheppard and Dr. Brett Thombs, by typing them into the discussion section of GotoMeeting.

You can access a transcript of the questions and answers here!

More information

COVID-19 and Scleroderma Q&A web-icon-pdf

Scleroderma Manitoba endorses The Scleroderma Foundation on COVID-19 for people with scleroderma: 
Information and Recommendations from The Scleroderma Foundation

COVID-19 and Scleroderma – Information and recommendations web-icon-pdf

Make the difference!

Every donation and effort help us to make a difference to advance research and to support people affected by scleroderma in Manitoba.  

Support research and scleroderma patients!